Next Article in Journal
Synthesis of 1,3,4-Thiadiazole, 1,3,4-Thiadiazine, 1,3,6-Thiadiazepane and Quinoxaline Derivatives from Symmetrical Dithiobiureas and Thioureidoethylthiourea Derivatives
Previous Article in Journal
Synthesis of Steroidal Thiadiazoles from Steroidal Ketones
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

3-Formylchromones IV. The Rearrangement of 3-Formylchromone Enamines as a Simple, Facile Route to Novel Pyrazolo[3,4-b]pyridines and the Synthetic Utility of the Latter

1
Department of Organic Chemistry Faculty of Natural Sciences, Comenius University, Slovakia
2
Institute of Chemistry, Swietokrzyska Academy, Poland
3
Institute of Chemistry, Faculty of Natural Sciences, Comenius University, Slovakia
4
EML Research, Villa-Bosch, Germany
*
Author to whom correspondence should be addressed.
Molecules 2005, 10(7), 809-821; https://doi.org/10.3390/10070809
Submission received: 8 May 2004 / Revised: 4 October 2004 / Accepted: 10 October 2004 / Published: 31 August 2005

Abstract

:
One-pot and facile preparations of 6-(2-hydroxy-5-R-benzoyl)-4-methyl-2-R1- pyrazolo[3,4-b]pyridines 4a-o are described, using the reaction of 3-formyl chromones 1 with 5-amino-1-R1-pyrazoles 2. An enamine-intermediate 2-ethyloxy-6-R-3-(3-methyl-1- phenylpyrazol-5-ylaminomethylene)chroman-4-one 3 was isolated at lower temperatures. Acyloxy-derivatives 5 of compounds 4 were obtained by acylation with acid chlorides or acid anhydrides. Coumarins 6 substituted at the 3- and 4-positions were prepared from the pyrazolo[3,4-b]pyridines 4 by condensation reactions and hydrazones 7 were formed from their reaction with 2,4-dinitrophenyl hydrazine. Reactions under microwave irradiation proceeded significantly faster and with high yields.

Introduction

In our previous synthetic and theoretical studies [1,2] we reported on the reactions of 3-formyl chromones 1 with primary amine derivatives of benzothiazole and aromatic acids, respectively. These studies confirmed that the investigated amines undergo 1,2- or 1,4-additions to 3-formyl chromones 1, forming a chroman-4-one enamine system as a main product. The relevant theoretical and kinetic studies of the reaction pathways of some 2- and 3-formylchromones with amine derivatives were published in the preceding papers [3,4,5,6] of this series. In general, 3-formylchromones 1 readily react with primary amines in an alcoholic medium yielding an enamine-adduct which rarely reacts further to give the corresponding Schiff base [7,10,11]. The important role of 3-formylchromones 1 as versatile synthons in heterocyclic chemistry as well as their pharmaceutical importance is well known [8,9,11]. These compounds also have interesting photochemical properties [7].
Our investigations of influence of microwave radiation – a widely used way to selectively excite primarily the polar components of reactants and solvent – on 3-formylchromone reactions were also reported elsewhere [12,13]. The main goal of this work was to examine the reaction of 1-substituted 5- aminopyrazoles 2 with 3-formylchromones 1 using classical and microwave heating, respectively.

Results and Discussion

In this article we report on a very convenient and smooth, one-pot method for the preparation of substituted 3-(2-hydroxybenzoyl)pyrazolo[3,4-b]pyridines 4a-o. Our results demonstrate a straight-forward entry to these pyrazolo[3,4-b]pyridine derivatives, which contain synthetically useful hydroxyl and carbonyl groups, and are formed via opening of the γ-pyrone ring and subsequent rearrangement of intermediate I1 with electrophilic substitution on the pyrazole ring. The 3-formylchromone starting compounds 1 are easily available from phenols according to Nohara [14,15].
This synthesis of pyrazolo[3,4-b]pyridine derivatives 4a-o was found to be very simple. Products were obtained by heating to reflux an equimolar mixture of 3-formylchromones 1 and 5-amino-pyrazole (2) in ethanol, using p-toluenesulfonic acid as catalyst (Scheme 1). The duration of the reflux (2 to 4 hours) was found to be important for the purity of the final rearranged products. The progress of the reaction can readily be monitored visually. Products 4 are of a pale yellow to white color but the intermediates are bright yellow.
The reaction kinetics depend on the substituents R, R1 and the solvent used. It was found that the methyl group (+I, +M effects) and similar substituents (H-) speeded up the formation of the final products. On the other hand, the compounds containing nitro groups on the chromone or pyrazole rings remained longer in the intermediate state (4 hours) before completing the reaction.
Ethanol was found to be more suitable for the synthesis of compounds 4 than other representative solvents like dioxane or toluene, as compared to these, ethanol facilitated faster reactions with higher yields and gave better product purities. This work as well as the previous kinetic studies [6] showed that alcohols are in general very good solvents for all reaction intermediates. This observation can be understood by noting that an alcohol, as a weak nucleophile, takes on a catalytic and stabilizing function after addition on to the chromanone ring and to the intermediates of this many-step-reaction, whereby forming complexes with lower energy.
Scheme 1.
Scheme 1.
Molecules 10 00809 g001
In Scheme 1 a probable mechanism for the formation of compounds 4 is proposed. Our synthetic studies and kinetic measurements [6] showed that step ii – addition of aminopyrazole and alcohol to the aldehydes – is faster then the subsequent step iv which includes electrophilic attack of the opened chromanone system (intermediate I1) at the C-12 position of pyrazole ring and rearrangement. The shorter reaction time resulted in a final product with a certain amount of impurities. The 1H-NMR-spectra and TLC showed that enamine-adducts or opened-intermediates I1 are the main impurities in the final products 4. We observed that prolonging the duration of the reflux in ethanol provided the products 4 with higher purity. These products 4 are stable enough and further heating in ethanol does not change the composition of the reaction mixtures.
The role of the enamine-adduct 3a as a reaction intermediate was confirmed by its isolation from the reaction mixtures at lower temperature (-10°C). Nitro derivative 3b show higher stability than the methyl analogue, and can still be isolated as the main product even after 20 minutes of reflux. Enamines, too, rearrange into the final products 4 after prolonged refluxing of the reaction mixtures.
Synthesis under microwave irradiation proceeded significantly faster. The reaction time dropped down to 6 to 25 minutes under exposure to microwaves at 800 W and produced clean products 4 in high yields (90%). However, no isolation of intermediate 3 was possible in this case.
The structures of the rearranged compounds were proven by elemental analysis and by 1H- and 13C-NMR spectra. The assignment of the 1H chemical shifts was deduced from the signal multiplicities and from the HH COSY spectra. The appropriate assignment of the 13C chemical shifts was based on the HMQC spectra for the C-H carbons and for the quaternary carbons from the coupled 13C spectrum (compound 4a). All of the NMR spectra indicate that the products 4 contain the pyridine ring. This conclusion is based on the observation of typical pyridine-ring shift values of 8.96 (H-2) and of 8.46 (H-4) respectively, and of their coupling constant J(2,4)=1.1 Hz (for compound 4a). The presence of the doublet-doublet signal in the 13C coupled spectrum at 151.5 δ (C-4a), with the coupling constants 3J(C, H-2) = 13.4 Hz and 3J(C, H-4) = 6.8 Hz confirms that the pyrazole ring is connected with the pyridine ring in the (3,4-b) position.
The detailed analysis of the 13C-NMR data of compound 4a (R = H), used as a reference compound, is presented in Table 1. The similar data for the compounds bearing other R substituents are available upon request from the corresponding author.
The pyrazolopyridine products 4 as bifunctional compounds were used for preparation of acyl- 5, or coumarin derivatives 6. Compounds 5 were prepared from the compound 4 by a standard acylation process. 3',4'-Substituted coumarins 6 were prepared by intramolecular ring formation of compounds 5 or by condensation reaction with methylene compounds by heating for 7 - 8 hours at 140-150°C (Scheme 2). A very simple deacylation process was realized by heating of compounds 5 at 110°C in formamide (Scheme 2).
Scheme 2.
Scheme 2.
Molecules 10 00809 g002
The keto-groups of compounds 4 reacted with 2,4-dinitrophenylhydrazine at elevated temperature and formed hydrazones 7 (Scheme 3). Compounds 5, 6 and 7 were identified by their microanalyses and by 1H-NMR spectra.
Scheme 3.
Scheme 3.
Molecules 10 00809 g003

Conclusions

A simple, one pot and facile route for the preparation of 11-hydroxy-5-methyl-7-phenyl-3-(phenyloxo)pyrazolo[3,4-b]pyridine derivatives (4a-4o) from 4-oxo-4H[1]benzopyran-3-carbox-aldehydes 1 by classical and microwave irradiation heating was described. Thus, the 3-formyl-chromones 1 react with 5-amino-N-phenylpyrazole (2) under reflux in ethanol and, after opening of the pyrone ring and an intramolecular electrophilic attack of the pyrazole ring, form a new pyrazolopyridine system 4. An intermediate enamine-adduct 3 was isolated at lower temperature. Preparation of acyl derivatives 5, 3,4-substituted coumarins 6, and hydrazones 7 is also presented.

Acknowledgements

The financial support of the Slovak Grant Agency (Grant No1/5085/) is gratefully acknowledged.

Experimental

General

Melting points (uncorrected) of the synthesized compounds were determined on the Kofler block. The microanalyses (Carlo Erba Instrumentazione 1106) were in satisfactory agreement with the calculated values (the results for C, H, and N showed an agreement within ± 0.30%). The respective data are summarized in Table 1, Table 2, Table 3 and Table 4. Microwave assisted reactions were carried out in a Lavis–1000 MultiQuant microwave oven. The apparatus was adapted for laboratory application with magnetic stirring and an external reflux condenser. 1H-NMR spectra were measured at 300MHz, 13C-NMR spectra at 75MHz on a Varian Gemini 2000 NMR spectrometer. The HHCOSY and HMQC analysis were performed using the manufacturer’s software. Chemical shifts are given in δ-scale, coupling constants in Hz, TMS was used as an internal standard.

Synthesis of enamine adduct 3a

A mixture of equimolar amounts of 6-methyl-3-formylchromone (20 mmol) and 5-amino-N-phenylpyrazole (20 mmol) in ethanol (30 mL) containing a catalytic amount of 4-toluenesulfonic acid (6 mg) gave a yellow solid intermediate 3a after intensive stirring for 20 minutes at a temperature of – 15 °C. The yellow solid was quickly removed from the solvent by filtration and then washed twice with cold ethanol. The purification of compound 3a was performed by stirring in ethanol for 10 minutes at about 0 - 5° C , then the solvent was sucked away and the residue was dried in vacuum at room temperature.

Synthesis of enamine adduct 3b

A mixture of equimolar amounts of 6-nitro-3-formylchromone (20 mmol) and 5-amino-N-phenyl-pyrazole (20 mmol) in ethanol (30 mL) with 4-toluenesulfonic acid (6 mg) resulted in a yellow solid intermediate 3b after stirring for 20 minutes at 40-50° C. The product was removed by hot filtration, washed twice with ethanol and then dried under vacuum at room temperature.

Preparation of pyrazolo[3,4-b]pyridine derivatives 4a-4e,4g-4k (Classical conditions)

A mixture of equimolar amounts of the appropriate 3-formylchromone derivatives (20 mmol) and 5-amino-N-(R1)-pyrazole (20 mmol) in ethanol (30 mL) was stirring and heated at reflux with 4-toluenesulfonic acid (6 mg) for two hours. The pale-yellow crystalline products were isolated in about 85 % yields, and could be recrystallized from ethanol or toluene. NMR spectra of the prepared compounds 4 are given in Table 1 and Table 2.

Preparation of pyrazolo[3,4-b]pyridine derivatives 4f, 4l,4m,4n and 4o (Classical conditions)

A mixture of equimolar amounts of 6-nitro-3-formylchromone (20 mmol) and 5-amino-N-(R1)- pyrazole (R1 is 4-nitrophenyl) (20 mmol) in ethanol (30 mL) was heated with 4-toluenesulfonic acid (20 mg) for four hours. The yellow products were isolated at about 70 % yields, and were recrystallized from toluene or mixtures of ethanol-DMSO.

Microwave procedure for preparation of 4a-4o

The mixture described in the previous section was irradiated at 800 W. For obtain an optimal yield of products 4 the irradiation times were varied between 6 and 25 minutes (nitro-derivatives required longer react times, from 18 - 25 minutes). The solid compounds were filtered off and recrystallized from ethanol or mixtures of ethanol-DMSO. The pure products were obtained in about 90 % yield.

Preparation of compounds 5 by acylation: procedure for 5a,5b,5c (with acetic anhydride)

Pyrazolo[3,4-b]pyridine derivatives 4 (2 mmol ), anhydrous acetic anhydride (10 mL) and freshly melted sodium acetate (2 mmol) was stirred at 60 °C for 3 hours. Then the acetic anhydride was removed under vacuum and the residue was recrystallized from acetone or chloroform. The crystalline products were obtained in ca. 70 % yields.

Procedure for 5d,5e,5f (with acid chlorides)

A mixture of equimolar amounts of pyrazolo[3,4-b]pyridine derivatives 4 (2 mmol) and KOH (2.4 mmol) in anhydrous acetone (20 mL) was heated under reflux for 1 hour. Subsequently it was vigorously stirred and cooled down to -5 °C while small amounts of a solution of acyl chloride (2.4 mmol) in anhydrous acetone (15 mL) were added. Upon completion of the addition the stirring was continued for another 2 hours at the room temperature. Acetone was removed under vacuum. The residue was treated with water, filtered off and recrystallized from ethanol or acetone in about 70 % yields.

Preparation of coumarin derivatives 6a, 6b

Pyrazolo[3,4-b]pyridine derivatives 4 (2 mmol ), anhydrous acetic anhydride (20 ml), fresh melted sodium acetate (2mmol) and phenylacetic acid or phenylthioacetic acid (2.4 mmol) was stirred and heated under reflux for 6 hours. Then the acetic anhydride was removed in vacuum and the residue was crystallized from toluene. The crystal products were obtained in 65 % yields.

Preparation of hydrazone derivatives 7

The mixture of equimolar amounts of pyrazolo[3,4-b]pyridine (4) (1 mmol ) and 2,4- dinitrophenylhydrazine (1 mmol) in 10ml of acetic acid was heated and stirred for 15 minutes at 80 °C. The red crystal product was isolated after recrystallized from acetic acid in about 82 % yield.
Table 1. Physical data of the compounds 4
Table 1. Physical data of the compounds 4
No
-------
Yield
Compound name
Formula / MWMelting pointElemental analysis
4a
-------
89%
3-(2-hydroxybenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine
C20H15N3O2 329.4120 –121 °CCalc.: 72.94 %C; 4.59 %H; 12.76 %N
Found: 73.12 %C; 4.54 %H; 12.87 %N
13C-NMR (CDCl3) δ(ppm), J(Hz): 12.73 q, J(C,H)=127.9(C-8);
116.57q, 3J(C,H)=2.9(C-4a);
118.98dt, J(C,H)=162.3, 3J(C,H)=7.3 (C-12);
119.23dd, J(C,H)=163.6, 3J(C,H)=9.2(C-14);
119.59dt, 3 J(C,H)=4.7, 3J(C,H)=7.6(C-10);
121.45dt, J(C,H)=161.6, 3J(C,H)=7.5(C-17,21);
126.55dt, J(C,H)=162.9, 3J(C,H)=7.6(C-19);
127.54d, 3J(C,H-4)=8.0(C-5); 129.41dd, J(C,H)=161.5, 3J(C,H) = 8.3(C-18,20);
131.87dd, J(C,H)=166.1, 3J(C,H)=6.0(C-4);
133.27dd, J(C,H)=160.2, 3J(C,H)=9.0(C-15);
136.85dd, J(C,H)=159.8, 3J(C,H)=9.2(C-13);
139.24t, 3 J(C,H)=8.0(C16);144.50qd, 2J(C,H)=7.1, 3J(C,H)=2.5(C-16);
150.30dd, J(C,H)=183.3, 3J(C,H)=5.5(C-2);
151.54dd, 3J(C,H-2)=13.4, 3J(C,H-4)=6.8(C-7a);
163.43dd, 3J(C,H) 7.5,6.8 (C-11), 199.11t, 3J(C,H) = 4.4(C-9).
4b3-(2-hydroxy-5-methylbenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine
C21H17N3O2 343.4142-144 °CCalc.: 73.38 %C; 4.99 %H; 12.23%N
Found: 73.22 %C; 4.84 %H; 12.27 %N
-------
92%
4c3-(2-hydroxy-5-fluorobenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine
C20H14FN3O2 339.4155-156 °C-----
-------
87%
4d3-(2-hydroxy-5-bromobenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine
C20H14 BrN3O2 408.4162-163° CCalc.: 58.82 %C; 3.43 %H; 10.21%N
Found: 58.62 %C; 3.21 %H; 10.01 %N
-------
87%
4e3-(2-hydroxy-5-chlorobenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine
C20H14 ClN3O2 363.2160-162 °CCalc.: 65.97 %C; 3.84 %H; 11.54%N; 9.74 %Cl
Found: 66.22 %C; 3.88 %H;11.34%N; 9.70%Cl
-------
89%
4f3-(2-hydroxy-5-nitrobenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine
C20H14N4O4 374.4207-208 °CCalc.: 77.36 %C; 4.52 %H; 18.07%N
Found: 77.48 %C; 4.58 %H; 18.14%N
-------
70%
4g3-(2-hydroxy-5-methylbenzoyl)-5-methyl-7-(4-nitrophenyl)pyrazolo[3,4-b] pyridine
C21H16N4O4 388.4224-226 °CCalc.: 64.94 % C; 4.15 % H; 14.43 % N
Found: 64.78 % C; 4.03 % H; 14.37 % N
-------
73%
4h3-(2-hydroxy-5-fluorobenzoyl)-5-methyl-7-4-(nitrophenyl)pyrazolo[3,4-b] pyridine
C20H13 FN4O4 392.4222 -224 °C----------
-------
87%
4i3-(2-hydroxy-5-bromobenzoyl)-5-methyl-7-(4-nitrophenyl)pyrazolo[3,4-b] pyridine
C20H13 BrN4O4 329.4260-261 °CCalc.: 53.00 % C; 2.89 % H; 12.36 % N; 17.63 %Br
Found: 53.19% C; 2.68 % H; 12.11% N;17.42 %Br
-------
82%
4j3-(2-hydroxy-5-chlorobenzoyl)-5-methyl-7-4-(nitrophenyl)pyrazolo[3,4-b] pyridine
C20H13 ClN4O4 408.8239-241 °CCalc.: 58.76% C; 3.21% H; 13.71% N; 8.67%Cl
Found: 58.67 %C; 3.11% H; 13.68% N; 8.58%Cl
-------
88%
4k3-(2-hydroxy-5-methylbenzoyl)-5,7-dimethylpyrazolo[3,4-b]pyridine
C16H15 N3O2 281.3176-177 °CCalc.: 68.31 %C; 5.37 % H; 14.94 % N
Found: 68.22 %C; 5.21 % H; 14.67 % N
-------
87%
4l3-(2-hydroxy-5-fluorobenzoyl)-5,7-dimethylpyrazolo[3,4-b]pyridine
-------C15H12 FN3O2 285.3160-161 °C-------------
87%
4m3-(2-hydroxy-5-bromobenzoyl)-5,7-dimethylpyrazolo[3,4-b]pyridine
-------C15H12BrN3O2 346.2150-151 °CCalc.: 52.04 %C; 3.49 %H; 12.14 % N; 23.08 % Br
Found : 52.19 %C; 3.32 %H; 12.11 % N; 23.17 % Br
89%
4n3-(2-hydroxy-5-chlorobenzoyl)-5,7-dimethylpyrazolo[3,4-b]pyridine
-------C15H12ClN3O2 301.7170-171 °CCalc.: 59.71 % C; 4.01% H; 13.93 % N; 11.75 %Cl
Found: 59.58 % C; 4.16% H; 14.11 % N; 11.42 %Cl
87%
4o3-(2-hydroxy-5-nitrobenzoyl)-5,7-dimethylpyrazolo[3,4-b] pyridine
-------C15H12 N4O4 312.3213-215 °CCalc.: 57.69 % C; 3.87 %H; 17.94 % N
Found : 57.53 % C; 3.68 %H; 18.11 % N
86%
Table 2. 1H-NMR spectral data of pyrazolo[3,4-b]pyridines 4
Table 2. 1H-NMR spectral data of pyrazolo[3,4-b]pyridines 4
NoRR1/8OH2412131517(21)(2H)18(20)(2H)19
4aH-14 7.63dd, J= 8.0
J= 1.4
2.71s11.86s8.96d, J=2.18.46d, J = 2.17.13dd, J = 8.2,
J = 1.1
7.57td J= 8.2,
J = 1.4
7.63dd, J = 8.0
J= 1.4
8.26dd J= 7.5 J=1.17.55t J= 7.57.34t J= 7.5
J= 1.1
4bCH32.28s
2.64s
11.06s8.94d J=1.98.47d J=1.97.04d J=7.77.38dd
J=7.8 J=0.8
7.39t
J=3.1 J=2.6
8.26dd,2H
J=7.6 J=1.1
7.55t,2H
J=7.6 J=1.1
7.34tJ=7.6 J=1.1
4cF2.72s11.57s8.95d J=1.98.45d J=1.97.10dd J11,12=10.2 J11,F = 4.47.2-7.4 m
3H*
13,15,19
*8.25dd,2H J=8.0 J=1.17.55t,2H J=8.0 J=1.1*
4dBr2.73s11.75s8.94d J=1.98.46d J=1.97.05d J=8.87.64dd
J=8.8 J=2.5
7.38t J=7.78.25dd,2H
J=7.7 J=1.1
7.56t,2H
J=7.7 J=1.1
7.38t
J=7.7 J=1.1
4eCl2.73s11.74s8.95d J=2.18.47d J=2.17.10d J=9.07.51dd
J=9.0 J=2.5
7.60d J=2.58.25dd,2H
J=7.7 J=1.1
7.56t,2H
J=7.7 J=1.1
7.35t
J=8.0 J=1.1
4fNO22.73s12.60s8.99d J=2.08.49d J=2.07.23d J=9.08.46dd
J=9.0 J=2.6
8.65d J=2.68.25dd,2H
J=7.6 J=1.1
7.56t,2H
J=7.5 J=1.1
7.55t
J=7.5 J=1.1
4gCH32.28s10.21s8.95d8.71d6.92d7.29dd7.33d8.48dd,2H8.67dd,2H

---
2.68s J=1.9J=1.9J=8.2J=8.2J=2.2J=9.4J=9.4
J=2.2 J=1.9J=1.9
4hF2.67s10.08s8.97d8.69d7.05dd7.2-7.3mH-13,158.41dd,2H8.62dd,2H
J=2.2J=2.2J=8.82H J=9.3J=9.3---
J=4.4 J=1.1J=1.9
4iBr2.67s10.37s8.95d8.68d7.00d7.53dd7.33d8.41dd,2H8.60dd,2H
J=1.9J=1.9J=8.6J=8.6J=2.2J=9.2J=9.2---
J=2.6J=2.0J=2.0
4jCl2.68s10.37s8.96d J=1.98.69d J=1.97.05d J=8.57.47dd
J=8.5 J=2.7
7.45d J=2.78.43dd,2H
J=9.3 J=2.2
8.62dd,2H
J=9.3 J=2.2

---
NoRR18OH24121315
4kCH32.28s
2.64s
4.15s11.67 s8.87d J=1.98.40d J=1.97.04t J=9.1
J=4.4
7.34-7.39m, (2H) 13, 15*
4lF2.63s4.15s11.56s8.87d J=2.08.39d J=2.07.11dd J=8.9 J=4.67.31td J=8.9 J=3.1
J=2.6
7.29t J=3.1 J=2.6
4mBr2.63s4.15s11.74s8.86d J=1.98.38d J=1.97.04d J=8.87.63dd J=8.8
J=2.4
7.69d J=2.4
4nCl2.65s4.16s11.74s8.87d J=2.08.39d J=2.07.09d J=8.97.51dd J=8.9
J=2.5
7.56d J=2.4
4oNO22.62s4.17s12.50s8.91d J=2.08.42d J=2.07.22d J=8.97.44dd J=8.9
J=2.7
8.61d J=2.7
* multiplet
Table 3. 13C-NMR: δ(ppm), J (Hz )(CDCl3)
Table 3. 13C-NMR: δ(ppm), J (Hz )(CDCl3)
NoRN-CH3C 14(CH3)8(CH3)2344a
4bCH3 20.7312.72150.23127.76130.92116.72
4cF 12.76150.14127.02131.86116.63
4dBr 12.76150.11126.92132.01116.73
4eCl 12.76150.11126.91131.96116.57
4mBr33.73 12.52149.75125.86132.21114.41
NoR57a910111213
4bCH3144.48151.5199.04119.31161.37118.74137.93
4cF144.61151.6198.19d
4JC,F=2,5
119.11d
JC,F=6.3
159.59120.38d
3JC,F =7,4
124.45d
2JC,F=23.8
4dBr144.61151.6198.08120.87161.30121.01139.52
4eCl144.61151.6198.14120.2161.84120.62136.72
4mBr142.93151.9198.28120.89162.18120.56139.02
NoR14151617,2118,2019
4bCH3128.45132.88139.25121.48129.41126.54
4cF155.02d
1JC,F=246.5
117.98d
2JC,F=23.8
139.11121.54129.45126.68
4dBr110.89135.07139.21121.58129.46126.72
4eCl124.07132.07139.24121.54129.44126.69
4mBr110.51135.13------------------------------
Table 4. Physical and 1H-NMR data for compounds 3,5,6,7
Table 4. Physical and 1H-NMR data for compounds 3,5,6,7
No
-------
Yield
Compound name
Formula / MWMelting pointElemental analysis
NMR data (CDCl3 unless otherwise indicated) [δ(ppm) , J (Hz )]
3a
-------
72%
2-Ethyloxy-6-methyl-3-(3-methyl-1-phenylpyrazol-5-ylaminomethylene)chroman-4-one
C23H23N3O3 383.5164 – 166 °CCalc.: 70.93%C; 5.95%H; 10.79%N
Found: 70.90%C; 6.01%H; 10.59%N
1H-NMR: 1.24 (t, 3H, CH3); 2.17 (s, 3H, CH3 on C-14), 2.49 (s, 3H, CH3 -6); 3.71 (q, 2H, CH2); 6.25 (s, 1H, H-2); 7.37- 7.42 (m, 3H, H-18,19,20); 7.52 (dd, 2H, 3J =8.4, 4J =2, H-17,21); 7.56 (d, 1H, 3J =8.4, H-8); 7.65 (dd, 1H, 3J =8.4, 4J =2, H-7); 7.67 (d, 1H, 4J =2, H-5); 8.08 (s, 1H, H-9); 8.67 (s, 1H, H-10); 8.99 (d, 1H, 4J =2, H-15); 9.02 (d, 1H, 4J =2.4, NH).
3b
-------
61%
2-Ethyloxy-6-nitro-3-(3-methyl-1-phenylpyrazol-5-ylaminomethylene)chroman-4-one
C22H20N4O5 420.4187 – 189 °CCalc.: 62.85%C; 4.75%H; 13.33%N
Found: 61.40%C; 4.63%H; 13.19%N
1H-NMR: 1.25 (t, 3H, CH3); 2.70 (s, 3H, CH3 on C-14); 3.91 (q, 2H, CH2); 6.37 (s, 1H, H-2); 7.35 (t, 1H, 3J =7.4, H-19); 7.52-758 (m, 2H, H-18,20); 8.24 (m, 2H, H-17,21); 8.35 (d, 1H , 3J =7.7, H-8); 8.42 (dd, 1H, 3J =7.7, 4J =2.7, H-7); 8.48 (d, 1H, 3J = 2.4, H-9); 8.64 (d,1H, 4J =2.7, H-5); 8.98 (d,1H,4J =2.0, H-15); 9.02 (d, 1H, 4J =2.4, NH)
5a
-------
68%
3-(2-acetyloxybenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine
C22H17N3O3 371.2109-111 °CCalc.: 71.12 %C; 4.58 %H, 11.31%N
Found: 71.26 %C; 4.50 %H, 11.28%N
1H-NMR: 2.03 (s, 3H, CH3CO); 2.68 (s, 3H, CH3-8); 7.30 (dd, 1H, 3J=7.3, 4J=2.1, H-13); 7.32-7.39 (m, 3H, H-11,18,20); 7.49-7.56 (m, 2H,H-10,12), 7.55 (t,1H, 3J=7.6, H-14); 8.26 (dd, 2H, 3J=7.7, 4J= 2.1, H-19,21); 8.48 (d, 1H, 4J=1.2,H-4); 9.05 (d, 1H, 4J=1.2, H-2)
5b
-------
61%
3-(2-acetyloxy-5-methylbenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine
C23H19N3O3 385.2125-127 ° CCalc.: 71.65 %C; 4.93 %H, 10.90%N
Found: 71.44 %C; 5.09 %H, 10.81%N
1H-NMR: 1.99 (s, 3H, CH3CO); 2.40 (s, 3H, CH3 on C-20); 2.67 (s, 3H, CH3-8); 7.11 (d, 1H, 3J=8.3, H-18); 7.30 (dd, 1H, 3J=7.3, 4J=2.1, H-19); 7.35 (d, 1H, 4J=2.2, H-21); 7.39 (m, 1H, H-14); 7.55 (t, 2H, 3J=7.6, H-10,12); 8.23 (dd, 2H, 3J=7.6, 4J=1.1, H-11,13); 8.49 (d, 1H, 4J(2,4)=1.2, H-4); 9.04 (d, 1H, 4J=1.2, H-2).
5c
------
58%
3-(2-ethyloxycarbonyloxy-5-methylbenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]-pyridine
C24H21N3O4 415.4154-156 ° CCalc.: 69.39 %C; 5.09 %H; 10.11%N
Found: 69.48 %C; 5.00 %H; 10.02%N
1H-NMR:1.07 (t,3H, 3J=7,3,CH3); 2.55 (s,3H,CH3); 2.66 (s, 3H, CH3-8); 4.09 (q,2H, 3J=7,3, CH2 ); 7.23 (t, 1H, 3J=8.3, H-18); 7.37 (d, 1H, 3J=8.3, H-12); 8.09 (tt, 2H, 3J=7.6, H-11,13); 8.24 (dd, 2H, 3J=8.8, 4J=1.1, H-17,21); 8.49 (d, 1H, 4J=1.3, H-4); 9.04 (d, 1H, 4J=1.3Hz, H-2).
5d
-------

63%
3-[2-(3-methylphenyloxyacetyloxy-5-methyl)benzoyl]-5-methyl-7-phenylpyrazolo[3,4-b]-pyridine
C30H25N3O4 491.3118-120 ° CCalc.: 73.27%C; 5.09 %H, 8.55%N
Found: 73.24%C; 5.19 %H, 8.41%N
1H-NMR: 2.41 (s, 3H, CH3); 2.25 (s, 3H, CH3); 2.64 (s, 3H, CH3-8); 4.62 (s, 2H, CH2); 6.73 (d, 1H, 4J=2.1, HPhO); 7.06-7.13 (m, 3H, HPhO); 7.3-7.4 (m, 3H, H-12,18,19); 7.45 (dd, 2H, 3J=7.3, 4J=2.1, H-11,13); 8.23 (dd, 2H, 3J=7.3, 4J=2.1, H-10,14); 8.47 (d, 1H, 4J=1.1, H-4); 9.04 (d, 1H, 4J=1.1, H-2).

6a
-------
68%
3-(6'methyl-3'-phenylcoumarin-4'-yl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine
C29H21N3O2 443.3 222-224 °CCalc.: 78.50 %C; 4.73 %H, 9.47%N
Found: 78.26 %C; 4.69 %H, 9.28%N
1H-NMR: 2.29 (s, 3H, CH3); 2.59 (s, 3H, CH3-8); 6.95 (s, 1H, H-5'); 7.1-7.2 (m, 5H, Ph on 3'); 7.29 (t, 1H, 3J=7.3, 4J=1.9, H-12); 7.38 (dd, 2H, 3J=7.3, J=1.9, H-11,13); 7.51 (d, 1H, 3J=7.4, H-8'); 7.54 (dd, 3J=7.4, 4J=1.9, H-7'); 7.78 (d, 1H, 4J=1.2, H-4); 8.23 (dd, 2H, 3J=7.6, 4J=2.0, H-10,14); 8.39 (d, 1H, 4J=1.2, H-2).
6b
-------
61%
3-[(6'methyl-3'-phenylthio)coumarin-4'-yl]-5-methyl-7-phenylpyrazolo[3,4-b]pyridine
C29H21N3O2S 475.2319-323 ° CCalc.: 67.12 %C; 4.52 %H, 11.18%N
Found: 66.98 %C; 4.35 %H, 11.28%N
1H-NMR (DMSO-d6): 2.25 (s, 3H, CH3 ); 2.62 (s, 3H, CH3-8 ); 6.97 (s, 1H, H-5'); 7.1-7.2 (s, 5H, Ph on 3'); 7.33 (t, 1H, 3J=7.5, 4J=1.9, H-12); 7.48 (d,1H, 3J=8.1, H-8'); 7.52-7.55 (m, 2H, H-11,13 ); 7.56 (dd, 1H, 3J=8.3, 4J=1.9, H-7'); 8.26 (dd, 2H, 3J=8.6, 4J=2.0, H-10,14); 8.39 (d, 1H, 4J=1.2, H-4); 8.64 (d, 1H, 4J=1.2, H-2).

7a
-------
63%
3-(2-hydroxybenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine-15-(2',4'-dinitrophenyl)hydrazone
C26H19N7O5 509.5280-281 °CCalc.: 61.23 %C; 3.73 %H, 19.24%N
Found: 61.45 %C; 3.40 %H, 19.02%N
1H-NMR: 2.72 (s, 3H, CH3); 6.82-6.86 (m, 2H, H-19,21); 7.13 (dd, 1H, 3J=8.3Hz, 4J=2 Hz, H-18); 7.32-7.43 (m, 2H, H-12,20); 7.56 (t, 2H, 3J=7.9Hz, 4J=2Hz, H-11,13); 8.17 (d, 1H, 4J=1.6Hz, H-4); 8.27 (d, 1H, 3J=8.9Hz, H-6'); 8.28 (dd, 2H, 3J=7.9Hz, 4J=1.9Hz, H-10, 14); 8.45 (dd, 1H, 3J=9 Hz, 4J=2Hz, H-5'); 8.59 (d, 1H, 4J=1.6Hz, H-2); 9.09 (d, 1H, 4J=2Hz, H-3'); 11.26 (s, NH); 11.37 (s, OH).
7b
-------
68%
3-(2-hydroxy-5-methylbenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine-15-(2', 4'-dinitrophenyl)hydrazone
C27H21N7O5 523.5290-292 °CCalc.: 61.89 %C; 4.01 %H, 18.72%N
Found: 61.78 %C; 4.11 %H, 18.53%N
1H-NMR: 2.26 (s, 3H, CH3); 2.75 (s, 3H, CH3-8); 6.58 (s, 1 H, H-21); 7.05 (d, 1H, 3J=8.5Hz, H-18); 7.17 (dd, 1H, 3J=8.6Hz, 4J=2.4Hz, H-19); 7.34 (t, 1H, 3J=7.6Hz, 4J=1.1Hz, H-12); 7.55 (dd, 2H, 3J=8.5Hz, 4J=2Hz, H-11,13); 7.75 (dd, 1H,3J=8.4Hz, 4J=2.5Hz, H-6'); 8.32 (dd, 2H, 3J=8.1Hz, 4J=2Hz, H-10,14); 8.44 (dd, 1H, 3J=9.1Hz, 4J=2.6Hz, H-5'); 8.15 (d, 1H, 4J=2.8Hz, H-4); 8.57 (d, 1H, 4J=2.0, H-2); 9.07 (d, 1H, 4J=2.6 H-3'); 11.13 (s, NH); 11.20 (s, OH).
7c
-------
70%
3-(2-hydroxy-5-fluorobenzoyl)-5-methyl-7-phenylpyrazolo[3,4-b]pyridine-15-(2', 4'-dinitrophenyl)hydrazone
C26H18FN7O5 528.4291-292 °C-----------------
1H-NMR: 2.66 (s, 3H, CH3); 6.94 (dd, 1H, 3J=8.8Hz, 4J=2.4Hz, H-19); 7.12 (d, 1H, 3J=8.8Hz, H-18); 7.51 (t, 1H, 3J=8.8Hz, 4J=2Hz, H-12); 7.56 (d, 1 H, 4J=2.4Hz, H-21); 8.14 (d, 1H, 4J=1.9Hz, H-4); 8.16 (dd, 2H, 3J=8.8Hz, 4J=2 Hz, H-11,13); 8.39 (dd, 1H, 3J=9.1Hz, 4J=2.6 Hz, H-5'); 8.43 (dd, 2H, 3J=8.1Hz, 4J=2Hz, H-10,14); 9.07 (d, 1H, 4J=1.9Hz, H-2); 9.09 (d, 1H, 4J=2.6 Hz, H-3'); 11.06 (s, NH); 11.27 (s, OH).

References

  1. Stankovičová, H.; Lácová, M.; Gáplovský, A.; Chovancová, J.; Pronayová, N. Tetrahedron 2001, 57, 3455.
  2. Stankovičová, H.; Fabian, W.M.F.; Lácová, M. Molecules 1996, 1, 223.
  3. Stankovičová, H.; Gašparová, R; Lácová, M.; Chovancová, J. Collect. Czech. Chem. Commun. 1997, 62, 781.
  4. El-Shaaer, H.M.; Perjessy, A.; Záhradník, P.; Lácová, M. Collect. Czech. Chem. Commun. 1994, 59, 1673.
  5. El-Shaaer, H.M.; Perjessy, A.; Záhradník, P.; Lácová, M.; Šusteková, Z. Monatsh. Chem. 1993, 124, 539.
  6. Stankovičová, H.; Gáplovský, A.; Lácová, M.; Puchala, A.; Chovancová, J. J. Am. Chem. Soc. (in press).
  7. Gáplovský, A.; Donovalová, J.; Lácová, M.; Mračnová, R.; El-Shaaer, H.M. J. Photochem. Photobio.- A: Chem. 2000, 136, 61.
  8. El-Shaaer, H.M.; Foltínová, P.; Lácová, M.; Chovancová, J.; Stankovičová, H. Il Farmaco 1998, 53, 224. [PubMed]
  9. Gašparová, R.; Lácová, M.; EL-Shaaer, H.M. Il Farmaco 1997, 52, 251. [PubMed]
  10. Gosh, Ch.K. J. Hetrocycl. Chem. 1983, 20, 1437. [CrossRef]
  11. Sabitha, G. Aldrichim. Acta 1996, 29, 15.
  12. Gašparová, R.; Lácová, M. Collect. Czech. Chem. Commun 1995, 60, 1178. [PubMed]
  13. Lácová, M.; Gašparová, R.; Loos, D.; Liptay, T.; Pronayová, N. Molecules 2000, 5, 167.
  14. Nohara, A.; Umetani, T.; Sanno, Y. Tetrahedron Lett. 1973, 14, 1995.
  15. Nohara, A.; Umetani, T.; Sanno, Y. Tetrahedron 1974, 30, 3553. [CrossRef]
  • Sample Availability: Contact the authors

Share and Cite

MDPI and ACS Style

Lacova, M.; Puchala, A.; Solcanyova, E.; Lac, J.; Kois, P.; Chovancova, J.; Rasala, D. 3-Formylchromones IV. The Rearrangement of 3-Formylchromone Enamines as a Simple, Facile Route to Novel Pyrazolo[3,4-b]pyridines and the Synthetic Utility of the Latter. Molecules 2005, 10, 809-821. https://doi.org/10.3390/10070809

AMA Style

Lacova M, Puchala A, Solcanyova E, Lac J, Kois P, Chovancova J, Rasala D. 3-Formylchromones IV. The Rearrangement of 3-Formylchromone Enamines as a Simple, Facile Route to Novel Pyrazolo[3,4-b]pyridines and the Synthetic Utility of the Latter. Molecules. 2005; 10(7):809-821. https://doi.org/10.3390/10070809

Chicago/Turabian Style

Lacova, M., A. Puchala, E. Solcanyova, J. Lac, P. Kois, J. Chovancova, and D. Rasala. 2005. "3-Formylchromones IV. The Rearrangement of 3-Formylchromone Enamines as a Simple, Facile Route to Novel Pyrazolo[3,4-b]pyridines and the Synthetic Utility of the Latter" Molecules 10, no. 7: 809-821. https://doi.org/10.3390/10070809

Article Metrics

Back to TopTop